Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedegund Meier

Showing results (51-60 of 234) with videos related to

Pageof 24
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanomaFriedegund Meier, Birgit Schittek, Silke Busch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
8. Virtuelles Netzwerktreffen der zertifizierten Hautkrebszentren 21.01.2022Frank Meiß, Thomas K Eigentler, Margit Huber, et al.
Cancer|February 29, 2008
Age and gender are significant independent predictors of survival in primary cutaneous melanomaKonstantinos Lasithiotakis, Ulrike Leiter, Friedegund Meier, et al.
Cancers|December 9, 2023
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated MelanomaHeike Niessner, Anna Hüsch, Corinna Kosnopfel, et al.
European Radiology|November 11, 2017
Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanomaPhilippe L Pereira, Kristina Krüger, Ernst Hohenstein, et al.
Clinics in Dermatology|June 15, 2010
Melanoma staging: facts and controversiesAndrea Forschner, Thomas Kurt Eigentler, Annette Pflugfelder, et al.
Clinics in Dermatology|June 15, 2010
Incisional biopsy and melanoma prognosis: Facts and controversiesAnnette Pflugfelder, Benjamin Weide, Thomas Kurt Eigentler, et al.
Plos One|August 8, 2024
General practitioners' perspectives on statutory skin cancer screening-A questionnaire-based cross-sectional survey in GermanyLydia Reinhardt, Cristin Strasser, Theresa Steeb, et al.
Melanoma Research|August 3, 2013
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanomaSail Abusaif, Zeinab Jradi, Laura Held, et al.
Melanoma Research|April 20, 2011
Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009Anne F Pfeil, Ulrike Leiter, Petra G Buettner, et al.
Pageof 24

Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanomaFriedegund Meier, Birgit Schittek, Silke Busch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
8. Virtuelles Netzwerktreffen der zertifizierten Hautkrebszentren 21.01.2022Frank Meiß, Thomas K Eigentler, Margit Huber, et al.
Cancer|February 29, 2008
Age and gender are significant independent predictors of survival in primary cutaneous melanomaKonstantinos Lasithiotakis, Ulrike Leiter, Friedegund Meier, et al.
Cancers|December 9, 2023
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated MelanomaHeike Niessner, Anna Hüsch, Corinna Kosnopfel, et al.
European Radiology|November 11, 2017
Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanomaPhilippe L Pereira, Kristina Krüger, Ernst Hohenstein, et al.
Clinics in Dermatology|June 15, 2010
Melanoma staging: facts and controversiesAndrea Forschner, Thomas Kurt Eigentler, Annette Pflugfelder, et al.
Clinics in Dermatology|June 15, 2010
Incisional biopsy and melanoma prognosis: Facts and controversiesAnnette Pflugfelder, Benjamin Weide, Thomas Kurt Eigentler, et al.
Plos One|August 8, 2024
General practitioners' perspectives on statutory skin cancer screening-A questionnaire-based cross-sectional survey in GermanyLydia Reinhardt, Cristin Strasser, Theresa Steeb, et al.
Melanoma Research|August 3, 2013
S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanomaSail Abusaif, Zeinab Jradi, Laura Held, et al.
Melanoma Research|April 20, 2011
Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009Anne F Pfeil, Ulrike Leiter, Petra G Buettner, et al.
Pageof 24